ADLM Advocates for Improved Pediatric Testing Access
The Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) highlights a crucial issue impacting children's health — the limited access to high-quality clinical laboratory services. This situation has raised a call to action demanding that Congress focusing on healthcare improvement, particularly through enhanced funding for essential programs.
Impact of Limited Access on Children's Health
Clinical laboratory testing serves as a vital component in diagnosing and managing pediatric patients. However, numerous hurdles disrupt children's access to these essential services. Key among these challenges is the escalating healthcare costs and the lack of price transparency, which render crucial laboratory tests unaffordable for many families. Even insured families often face high-deductible plans that lead to significant out-of-pocket costs, with a staggering 43% of insured patients unable to afford necessary pediatric care.
Disparities in Test Availability
The disparity in test availability across different states exacerbates the issue. For instance, while some states perform comprehensive newborn screening for over 70 genetic conditions, others lag significantly behind, screening only 33 conditions. This inconsistency leaves many children untested for potentially serious conditions, increasing the risk of misdiagnosis and inadequate treatment. Most laboratory reference intervals are based on adult populations, further complicating pediatric healthcare, as this can lead to incorrect treatment decisions.
Proposals for Congressional Action
To remedy these disparities, ADLM has proposed several concrete measures for Congress to consider:
- Boost funding for the Children's Health Insurance Program and enhance support for regional hospitals serving underserved pediatric populations.
- Expand funding initiatives for newborn screenings, ensuring that all states can perform tests listed in the Recommended Uniform Screening Panel for newborns.
- Allocate additional resources to the Centers for Disease Control and Prevention to establish pediatric-specific reference intervals, tailoring healthcare measures to this vulnerable population.
Healthcare Literacy and Transparency Improvements
The federal government is also urged to enhance health literacy, ensuring critical information is accessible to diverse communities. This approach empowers families to understand their healthcare choices, navigating the system more effectively. Furthermore, streamlining the Hospital Price Transparency Final Rule is essential to reduce confusion regarding the costs of healthcare services provided by hospitals. Close collaboration among patient advocacy groups, healthcare providers, and payers is necessary to create price transparency policies that prioritize patient needs without burdening them financially.
ADLM's Commitment to Children’s Healthcare
As ADLM President Dr. Anthony Killeen has stated, “Clinical laboratory services are crucial for the health of children, and improving access is essential, especially for the most vulnerable groups.” Acknowledging the efforts of Congress towards enhancing healthcare access, ADLM emphasizes the importance of increased funding and collaborative policymaking with laboratory medicine experts to ensure successful implementation of pediatric testing and broader healthcare services.
About ADLM
The Association for Diagnostics & Laboratory Medicine (ADLM) is dedicated to advancing health through laboratory medicine. By uniting over 70,000 laboratory professionals, physicians, researchers, and business leaders, ADLM promotes areas including clinical chemistry, molecular diagnostics, and lab management. With a history stretching back to 1948, ADLM continues to foster collaboration, knowledge sharing, and innovation within the field of laboratory science.
Frequently Asked Questions
What is the main message from ADLM regarding pediatric testing?
ADLM urges Congress to improve access to high-quality clinical laboratory testing for children, advocating for increased funding in critical healthcare programs.
Why is access to clinical laboratory testing important for children?
Clinical laboratory testing is essential for diagnosing and managing children's health issues, and limited access can lead to misdiagnosis and inadequate care.
What barriers do families face regarding pediatric testing?
High healthcare costs, limited test availability across states, and lack of price transparency hinder families from accessing necessary pediatric care.
What specific congressional actions does ADLM recommend?
ADLM recommends increasing funding for the Children's Health Insurance Program and newborn screening, as well as establishing pediatric reference intervals at CDC.
How does ADLM view the role of healthcare literacy in this context?
ADLM emphasizes that improving health literacy is crucial for empowering families to navigate the healthcare system effectively.
